Cargando…
Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
BACKGROUND: A tetravalent live attenuated dengue vaccine, Dengvaxia, sensitised naïve recipients to severe dengue illness upon a subsequent natural dengue infection and is suspected to be due to antibody-dependent enhancement (ADE). ADE has also been implicated in the severe neurological outcomes of...
Autores principales: | Shukla, Rahul, Beesetti, Hemalatha, Brown, Julia A., Ahuja, Richa, Ramasamy, Viswanathan, Shanmugam, Rajgokul K., Poddar, Ankur, Batra, Gaurav, Krammer, Florian, Lim, Jean K., Kale, Sachin, Lal, Altaf A., Swaminathan, Sathyamangalam, Khanna, Navin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7501058/ https://www.ncbi.nlm.nih.gov/pubmed/32949997 http://dx.doi.org/10.1016/j.ebiom.2020.102991 |
Ejemplares similares
-
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
por: Shukla, Rahul, et al.
Publicado: (2020) -
Cellular T-cell immune response profiling by tetravalent dengue subunit vaccine (DSV4) candidate in mice
por: Aggarwal, Charu, et al.
Publicado: (2023) -
Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement
por: Shukla, Rahul, et al.
Publicado: (2020) -
Sinococuline, a bioactive compound of Cocculus hirsutus has potent anti-dengue activity
por: Shukla, Rahul, et al.
Publicado: (2023) -
A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture
por: Raut, Rajendra, et al.
Publicado: (2015)